NEW YORK, March 2, 2017 /PRNewswire/ -- Pompe Disease Treatment
Read the full report: http://www.reportlinker.com/p04539048-summary/view-report.html
Lysosomalstorage diseases (LSDs) are a group of progressive, autosomal recessive, and hereditary disorders characterized by the accumulation of specific substrates and variable age of onset and clinical symptoms. Pompe disease, a type of LSD, is caused by mutations
Covered in this reportThe report covers the present scenario and the growth prospects of the global Pompe disease treatment market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the drugs available in the market and the drug candidates that are in various phases of development for the treatment of Pompe disease.
The market is divided into the following segments based on geography: - Americas- APAC- EMEATechnavio's report, Global Pompe Disease Treatment Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - Amicus Therapeutics- Audentes Therapeutics- Sanofi Genzyme Other prominent vendors- EpiVax - Oxyrane - Sangamo BioSciences - Valerion TherapeuticsMarket driver - Special regulatory drug designations for orphan drugs- For a full, detailed list, view our report Market challenge - Limited patient population- For a full, detailed list, view our report Market trend - Emergence of immunotherapy for Pompe disease- For a full, detailed list, view our report Key questions answered in this report- What will the market size be in 2020 and what will the growth rate be?- What are the key market trends?- What is driving this market?- What are the challenges to market growth?- Who are the key vendors in this market space?- What are the market opportunities and threats faced by the key vendors?- What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
MethodologyResearch methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.Read the full report: http://www.reportlinker.com/p04539048-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-pompe-disease-treatment-market-2016-2020-300417424.html
Subscribe to our Free Newsletters!
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...
Statins are a group of drugs which help to lower the blood cholesterol levels.View All